Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load.
about
High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failureCan biomarkers help to diagnose early heart failure with preserved ejection fraction?ST2 and IL-33 in pregnancy and pre-eclampsiaSerum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients.Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes?Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.Soluble ST2: a new and promising activity marker in ulcerative colitis.Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.A role for soluble ST2 in vascular remodeling associated with obesity in rats.Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcomeMyocardial pressure overload induces systemic inflammation through endothelial cell IL-33.Elevated Plasma Soluble ST2 Is Associated with Heart Failure Symptoms and Outcome in Aortic Stenosis.The Protective Role of Interleukin-33 in Myocardial Ischemia and Reperfusion Is Associated with Decreased HMGB1 Expression and Up-Regulation of the P38 MAPK Signaling PathwayAltered serum levels of IL-33 in patients with advanced systolic chronic heart failure: correlation with oxidative stress.Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study.Lysophosphatidic acid increases soluble ST2 expression in mouse lung and human bronchial epithelial cellsInterleukin-33, matrix metalloproteinase-9, and tissue inhibitor [corrected] of matrix metalloproteinase-1 in myocardial infarctionSoluble ST2 is regulated by p75 neurotrophin receptor and predicts mortality in diabetic patients with critical limb ischemiaSoluble Suppression of Tumorigenicity 2 and Echocardiography in Sepsis.Impact of diabetes on the predictive value of heart failure biomarkers.IL-33/ST2 pathway and classical cytokines in end-stage heart failure patients submitted to left ventricular assist device support: a paradoxic role for inflammatory mediators?Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillationBiomarkers of cardiovascular stress and incident chronic kidney disease.Soluble ST2 predicts elevated SBP in the communityGenetics of interleukin 1 receptor-like 1 in immune and inflammatory diseases.Role of IL-33 in inflammation and disease.The Presage(®) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2.Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.Circulating biomarkers in patients with heart failure and preserved ejection fraction.The emerging role of Galectin-3 and ST2 in heart failure: practical considerations and pitfalls using novel biomarkers.A novel cardiac bio-marker: ST2: a review.Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.Clinical relevance of sST2 in cardiac diseases.Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD.The role of cardiac biochemical markers in aortic stenosis.Biomarkers to Predict Reverse Remodeling and Myocardial Recovery in Heart Failure.Emerging Roles of IL-33/ST2 Axis in Renal Diseases.Temporal changes of soluble ST2 after cardiovascular interventions.Nasal administration of interleukin-33 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma surrogate.Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia - a longitudinal study.
P2860
Q24610732-1251011C-383B-4487-BFF2-F507CCD116D1Q28087822-CEA7BA3B-14B4-4830-BB55-11D9187D0189Q28740320-C0B23CBE-F648-4312-8C7F-EA35143EBC07Q33711545-AFCA09F3-CD7A-4D7E-817D-CF8716329635Q34462325-90C0069D-E51E-4AB3-A9FA-2032CC2BC83BQ34619975-E548BDED-3567-4BFA-A919-083B23128EA3Q34975712-26E8C3CF-A3A1-4BD0-97F6-ACFBBA673E4CQ35022269-D8044D5E-F6A5-4FA9-8CA7-B5BC584BB462Q35050444-80D73F2F-FB84-405C-8627-67018433D957Q35153947-1A56C507-BDBC-472E-8426-499DDA91C7DAQ35740288-0E5433FB-B22C-4D63-BF6D-1272951656DDQ35782067-15A6160D-FA96-4A69-A5EB-28CDBB3D0075Q35841956-FD9C602F-176C-44EB-83AC-D2CBD3E0C67FQ36445023-2C3BFBD4-724A-44E4-9619-811456A45D75Q36569151-B87C9FF8-07B5-4335-BB30-31EA2E0691D3Q36569198-FEFA3F9A-D8BF-4230-BD77-64D0D1BC9E35Q36705701-DC3B0EB2-75EB-448D-85AC-8B036C571F0BQ36739733-611CD49E-E026-4487-ABAD-38055398AB06Q37231531-8AE8F1B9-A235-43E6-99F0-0B9544CD0C84Q37390778-E9C2FFD1-76BC-4DD0-A086-77F5B0CA820CQ37413342-FB530AD1-B000-41EB-92DF-F52CDA0F0DFEQ37449938-6E10B092-AA7E-4D94-A49E-3F02982A01C3Q37678391-49D4F8F4-B382-4803-9FF5-D71AF6E9762EQ37702150-E1043CC5-F5A1-4B05-A1C3-936E9788618DQ37883044-8A86B9A7-E5F8-4056-803A-2F87DBC9A94FQ37922810-C11B2CB7-0B53-46E5-9429-A1F9C944644DQ38068933-DA421782-EC9F-45CD-A628-8A8A0B1C5018Q38110226-0C5C7287-A707-4140-88AD-B09A9CB03EABQ38152289-1AAA91EF-F14D-4D3C-9CCE-88A5F13CAC79Q38154222-6DD691E8-7706-4F79-B678-F695F66519D7Q38171069-28FC66CC-0889-4805-90FD-316694A20AA8Q38380593-76EEBAEC-1048-4E59-ADBD-085BC4AA24D9Q38626970-ED7F329A-98FC-4702-8A2E-49FF828CC84EQ38709053-E3214056-A6F0-4D9D-B98B-A36C4D84C014Q38743657-622E5239-6EC0-4574-98E3-CA514683329CQ38977493-3EC26BEE-8977-4293-99E1-F152A412772AQ39226501-445FCA8B-F2BB-4A05-87B5-5591159F6BB6Q39507885-E402DDD1-7634-45C9-AE43-33A98185310BQ39871685-0122985E-DC2D-4A93-A704-0B39CD7C8FE7Q40367971-BBA2522B-E6D5-46AD-BA3A-5BD0346B3D71
P2860
Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nonmyocardial production of ST ...... is related to diastolic load.
@en
Nonmyocardial production of ST ...... is related to diastolic load.
@nl
type
label
Nonmyocardial production of ST ...... is related to diastolic load.
@en
Nonmyocardial production of ST ...... is related to diastolic load.
@nl
prefLabel
Nonmyocardial production of ST ...... is related to diastolic load.
@en
Nonmyocardial production of ST ...... is related to diastolic load.
@nl
P2093
P2860
P1476
Nonmyocardial production of ST ...... is related to diastolic load.
@en
P2093
Bart De Wiest
Filip Casselman
Frederik Van Durme
Herbert de Raedt
Jaydeep Sarma
Jozef Bartunek
Leen Delrue
Lija Joseph
Marc Goethals
Marc Vanderheyden
P2860
P304
P356
10.1016/J.JACC.2008.09.027
P407
P577
2008-12-01T00:00:00Z